Other studies have shown that the aberrant expression of PSD95 is associated with schizophrenia, AD, Huntington's disease, autism spectrum disorders and pain disorder (Arbuckle et al., 2010; de Bartolomeis et al., 2014; Savioz et al., 2014; Zhang et al., 2014). This evidence concerns the gene DLG4 and autism spectrum disorder.